NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/27/2025
Back to search
Official data from USPTO
PHARMATECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
10/28/2025
Trademark type
Combined
Nice classes
5
Filing date
12/12/2018
Registration date
01/21/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/27/2025
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
11/30/2018
First use in commerce
11/30/2018
Drawing code
3
Owner type
03
Owner location
Miami, FL
Examiner
CARR,PATRICK C
Current location
Historical data usage
Mark description
The mark consists of the word "Pharmatech" in orange lettering with a green hyphen through the left side of the top half of the "P" all above a solid green bar and all to the left of a green image of an open hand with three leaves.
Holders and representatives
Holders
Pharmatech U.S.A. Corp.
Representatives
Moises Saltiel Saltiel Law Group
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplements; Dietary and nutritional supplements; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations
Publications
History of USPTO decisions and trademark events.
22 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/27/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/27/2025
E815
TEAS SECTION 8 & 15 RECEIVED
06/25/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/05/2019
PUBO
PUBLISHED FOR OPPOSITION
11/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/16/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/27/2019
DOCK
ASSIGNED TO EXAMINER
08/14/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2019
ALIE
ASSIGNED TO LIE
07/20/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/15/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/15/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/15/2019
CNSL
SUSPENSION LETTER WRITTEN
03/15/2019
DOCK
ASSIGNED TO EXAMINER
03/09/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2019
NWAP
NEW APPLICATION ENTERED
12/15/2018
Continuous trademark protection
Get notified about every new filing that threatens PHARMATECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.